Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
Top Hollywood agency CAA in talks to sell itself to Kering boss
2/2 © Reuters. FILE PHOTO: Cars are shown lined up at the valet parking area outside the Creative Artists Agency building in Los Angeles, California,
Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal
© Reuters. FILE PHOTO: A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer/File Photo (Reuters) – Biotech company Roivant
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
SoFi Technologies falls as Morgan Stanley says sell the stock By Investing.com
© Reuters. SoFi Technologies (SOFI) falls as Morgan Stanley says sell the stock Shares of SoFi Technologies (NASDAQ:) dropped 4% in pre-open trading Thursday following
Alibaba stock gains on report it may sell shares to Ant By Investing.com
© Reuters. Alibaba (BABA) stock gains on report it may sell shares to Ant Alibaba’s Hong Kong-listed shares (HK:) gained 3.2% on Monday after Bloomberg
Deal to Sell National Enquirer Collapses
Vinco Ventures, part of a group that agreed to buy the supermarket tabloid, found the transaction wasn’t in its best interest. Source link
FIS to Sell Majority Stake in Worldpay for $11.7 Billion
Private-equity firm GTCR will hold a 55% stake following the deal that values the payment processor at $18.5 billion. Source link
A New Home Is Crowned Priciest Property to Ever Sell in Paradise Valley
Be the first to know about the biggest and best luxury home sales and listings by signing up for our Mansion Deals email alert. In
Goldman Sachs Maintains Latham Group (SWIM) Sell Recommendation
Fintel reports that on April 11, 2023, Goldman Sachs maintained coverage of Latham Group (NASDAQ:SWIM) with a Sell recommendation. Analyst Price Forecast Suggests 96.76% Upside
